Aquaculture Fungal Infection Treatment Market

Aquaculture Fungal Infection Treatment Market Forecast and Outlook 2026 to 2036

Valuation of the global aquaculture fungal infection treatment market is projected to grow from USD 1.2 billion in 2026 to USD 3.1 billion by 2036, depicting a compound annual growth rate (CAGR) of 10.1% between 2026 and 2036. This translates into a total growth of 133.3%. The formalin-based treatments segment is set to register 38.0% of the aquaculture fungal infection treatment market in 2026.

Key Takeaways from Aquaculture Fungal Infection Treatment Market

• Aquaculture Fungal Infection Treatment Market Value (2026): USD 1.2 billion
• Aquaculture Fungal Infection Treatment Market Forecast Value (2036): USD 3.1 billion
• Aquaculture Fungal Infection Treatment Market Forecast CAGR: 10.1%
• Leading Treatment Category in Aquaculture Fungal Infection Treatment Market: Formalin-based treatments (38.0%)
• Key Growth Regions in Aquaculture Fungal Infection Treatment Market: North America, Europe, East Asia
• Key Players in Aquaculture Fungal Infection Treatment Market: Neogen Corporation, Zoetis Inc., Kemin Industries Inc., Elanco Animal Health Incorporated, Ceva Santé Animale

Formalin-based treatments in the aquaculture sector enable farm operators to deliver enhanced pathogen control capabilities and comprehensive disease management with improved treatment efficiency characteristics and consistent performance across multiple aquaculture deployment settings, providing superior cost-effectiveness characteristics for fungal infection control and prevention requirements.

Aquaculture farms are projected to register 68.0% of the aquaculture fungal infection treatment market in 2026. Aquaculture farms in operational environments enable advanced disease prevention protocols, standardized treatment quality procedures, and operational deployment optimization that are essential for fish health, quality adherence, and production performance environments.

Aquaculture Fungal Infection Treatment Market

Metric	Value
Estimated Value in (2026E)	USD 1.2 billion
Forecast Value in (2036F)	USD 3.1 billion
Forecast CAGR (2026 to 2036)	10.1%

Category

Category	Segments
Therapies	Formalin-based treatments; Malachite green alternatives; Iodophors; Others
Applications	Saprolegniasis; Branchiomycosis; Others
End User	Aquaculture Farms; Hatcheries; Veterinary Retail
Sales Channel	Direct Farm Sales; Veterinary Distributors; Specialty Aquaculture Suppliers; Others
Region	North America; Europe; East Asia; South Asia; Latin America; Middle East & Africa

Segmental Analysis

By Therapies, Which Segment Holds the Dominant Share in the Aquaculture Fungal Infection Treatment Market?

In terms of therapies, the formalin-based treatments segment leads the market with 38.0% share. Aquaculture professionals and disease management specialists increasingly utilize formalin-based treatment systems for their superior pathogen control properties and deployment efficiency characteristics.

• Manufacturing investments in advanced treatment formulations and aquaculture infrastructure continue to strengthen adoption among performance-focused commercial farming facilities.
• With aquaculture professionals prioritizing treatment system performance and pathogen elimination validation, formalin-based modules align with both efficiency objectives and fish health requirements, making them the central component of comprehensive disease management strategies.

By End User, Which Segment Registers the Highest Share in the Aquaculture Fungal Infection Treatment Market?

By end user, aquaculture farms dominates with 68.0% share, underscoring its critical role as the primary application category for farming facilities seeking superior disease control capabilities and enhanced treatment compliance credentials. Aquaculture specialists and farm management teams prefer fungal infection treatment solutions for commercial farming applications due to their established performance validation requirements.

• Farming facilities are optimizing treatment selections to support application-specific requirements and comprehensive disease management strategies.
• As aquaculture technology continues to advance and operators seek efficient farm management methods, commercial farming applications will continue to drive market growth while supporting treatment performance optimization and cost reduction strategies.

What are the Drivers, Restraints, and Key Trends of the Aquaculture Fungal Infection Treatment Market?

• Drivers: Farm operator demand for enhanced disease control performance and advanced fungal infection management initiatives drive mandatory adoption of high-performance treatment solutions across commercial aquaculture facilities.
• Restraint: High treatment costs and technical complexity of integrating specialized disease prevention protocols into existing farming procedures limit market penetration.
• Trend 1: Shift toward advanced treatment formulations that minimize fish mortality and reduce deployment costs for farm management.
• Trend 2: Development of specialized multi-functional compatibility systems supporting multiple aquaculture applications and fish species compatibility.

Analysis of the Aquaculture Fungal Infection Treatment Market by Key Country

Country	CAGR 2026 to 2036
China	11.5%
India	11.8%
Brazil	11.0%
Japan	7.1%
U.S.	9.6%
France	9.5%

The report covers an in-depth analysis of 40+ countries; top-performing countries are highlighted below.

What Opportunities Can Aquaculture Fungal Infection Treatment Providers Expect in China?

Revenue from aquaculture fungal infection treatment in China is projected to exhibit exceptional growth with a CAGR of 11.5% through 2036, driven by the country's rapidly expanding aquaculture infrastructure, regulatory frameworks promoting disease prevention efficiency initiatives, and programs supporting advanced treatment technologies across major aquaculture regions.

• Established farming infrastructure and expanding aquaculture capabilities are driving demand for fungal infection treatment solutions across commercial facilities, disease prevention developments, and comprehensive management systems throughout Chinese aquaculture markets.
• Strong regulatory development and technology initiatives are supporting the rapid adoption of premium disease management services among quality-focused operators seeking to meet evolving treatment standards and performance requirements.

What is the Indian Aquaculture Fungal Infection Treatment Market Size?

Revenue from aquaculture fungal infection treatment products in India is projected to expand at a CAGR of 11.8%, supported by rising aquaculture investment, growing fish farming consciousness, and expanding technology service capabilities. The country's developing infrastructure and increasing investment in disease prevention technologies are driving demand for treatment solutions across both traditional and modern aquaculture applications.

• Rising infrastructure development and expanding performance capabilities are creating opportunities for disease prevention adoption across aquaculture monitoring projects.
• Growing aquaculture awareness initiatives and treatment technology advancement are driving the adoption of specialized performance devices and services among farming users.

What is the Japanese Aquaculture Fungal Infection Treatment Market Size?

Revenue from aquaculture fungal infection treatment products in Japan is projected to expand at a CAGR of 7.1%, supported by rising aquaculture investment, growing fish farming consciousness, and expanding technology service capabilities. The country's advanced infrastructure and increasing investment in disease prevention technologies are driving demand for treatment solutions across both traditional and modern aquaculture applications.

• Advanced infrastructure development and expanding performance capabilities are creating opportunities for disease prevention adoption across aquaculture monitoring projects.
• Growing aquaculture awareness initiatives and treatment technology advancement are driving the adoption of specialized performance devices and services among farming users.

What is the U.S. Aquaculture Fungal Infection Treatment Market Size?

Revenue from aquaculture fungal infection treatment products in the U.S. is projected to grow at a CAGR of 9.6% through 2036, supported by the country's emphasis on treatment precision, disease prevention excellence, and advanced technology integration requiring efficient aquaculture solutions. American farm operators and performance-focused establishments prioritize performance monitoring and cost efficiency precision, making specialized treatment services essential components for both traditional and modern aquaculture applications.

• Advanced precision disease prevention technology capabilities and growing aquaculture applications are driving demand for treatment services across specialty performance applications.
• Strong focus on treatment precision and disease prevention excellence is encouraging users and service providers to adopt aquaculture solutions.

Competitive Landscape of the Aquaculture Fungal Infection Treatment Market

The aquaculture fungal infection treatment market is characterized by competition among established animal health manufacturers, specialized disease prevention service providers, and integrated aquaculture solution companies. Companies are investing in advanced treatment formulations, specialized performance platforms, innovation capabilities, and comprehensive service networks to deliver consistent, high-quality, and reliable treatment services.

Market players include Neogen Corporation, Zoetis Inc., Kemin Industries Inc., Elanco Animal Health Incorporated, Ceva Santé Animale, and others, offering commercial and farm services with emphasis on treatment excellence and disease prevention heritage. Neogen Corporation provides integrated treatment automation with a focus on aquaculture market applications and precision performance networks.

Key Players in the Aquaculture Fungal Infection Treatment Market

• Neogen Corporation
• Zoetis Inc.
• Kemin Industries Inc.
• Elanco Animal Health Incorporated
• Ceva Santé Animale
• Merck Animal Health
• Virbac
• Pharmaq
• HIPRA
• Benchmark Holdings

Scope of the Report

Items	Values
Quantitative Units (2026)	USD 1.2 Billion
Therapies	Formalin-based treatments, Malachite green alternatives, Iodophors, Others
Applications	Saprolegniasis, Branchiomycosis, Others
End User	Aquaculture Farms, Hatcheries, Veterinary Retail
Sales Channel	Direct Farm Sales, Veterinary Distributors, Specialty Aquaculture Suppliers, Others
Regions Covered	North America, Europe, East Asia, South Asia, Latin America, Middle East & Africa
Countries Covered	U.S., Japan, UK, Germany, China, India, and other countries
Key Companies Profiled	Neogen Corporation, Zoetis Inc., Kemin Industries Inc., Elanco Animal Health Incorporated, Ceva Santé Animale, and other leading animal health companies
Additional Attributes	Dollar revenue by therapy type, application, end user, sales channel, and region; regional demand trends, competitive landscape, technological advancements in treatment technology, farm performance optimization initiatives, disease prevention programs, and premium aquaculture development strategies

Aquaculture Fungal Infection Treatment Market by Segments

• Therapies :

  • Formalin-based treatments
  • Malachite green alternatives
  • Iodophors
  • Others

• Applications :

  • Saprolegniasis
  • Branchiomycosis
  • Others

• End User :

  • Aquaculture Farms
  • Hatcheries
  • Veterinary Retail

• Sales Channel :

  • Direct Farm Sales
  • Veterinary Distributors
  • Specialty Aquaculture Suppliers
  • Others

• Region :

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Nordic Countries
    • BENELUX
    • Rest of Europe
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia
    • India
    • Australia
    • Rest of South Asia
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Kingdom of Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of Middle East and Africa
  • Other Regions
    • Oceania
    • Central Asia
    • Other Markets

Bibliography

• International Aquaculture Technology Association Research Committee. (2023). Fungal infection treatment technologies and performance optimization in commercial aquaculture systems. International Aquaculture Technology Association.
• International Organization for Standardization. (2023). Aquaculture quality management: Assessment of fungal treatment technology, farm efficiency, and quality control of disease prevention systems (ISO Technical Report). ISO.
• European Committee for Standardization. (2022). Aquaculture quality management: Evaluation of disease prevention processing, quality control, and treatment compliance in commercial facilities (EN Technical Report). CEN.
• Journal of Aquaculture Disease Management Editorial Board. (2024). Disease prevention processing, quality control, and performance optimization in modern aquaculture facilities. Journal of Aquaculture Disease Management, 150(4), 245-262.
• Animal Health Technology Agency, Technical Committee. (2023). Advances in fungal treatment processing and quality control technologies for aquaculture and therapeutic applications. Animal Health Technology Agency.